Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Cancer
|
February 4, 2010
Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody
Frits Aarts, Otto C Boerman, Robert M Sharkey, et al.
Plos One
|
September 7, 2012
Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines
Chien-Hsing Chang, Yang Wang, Preeti Trisal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2006
Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group
Jean-François Chatal, Loïc Campion, Françoise Kraeber-Bodéré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors
Dieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells
Edmund A Rossi, Chien-Hsing Chang, Michele J Losman, et al.
EJNMMI Research
|
January 31, 2012
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method
Rafke Schoffelen, Winette Ta van der Graaf, Robert M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide
William J McBride, Pat Zanzonico, Robert M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial
Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2012
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers
Robert M Sharkey, Catharina M van Rij, Habibe Karacay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 22, 2004
Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates
Gary L Griffiths, Chien-Hsing Chang, William J McBride, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Cancer
|
February 4, 2010
Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody
Frits Aarts, Otto C Boerman, Robert M Sharkey, et al.
Plos One
|
September 7, 2012
Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines
Chien-Hsing Chang, Yang Wang, Preeti Trisal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2006
Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group
Jean-François Chatal, Loïc Campion, Françoise Kraeber-Bodéré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors
Dieter Moosmayer, Dietmar Berndorff, Chien-Hsing Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells
Edmund A Rossi, Chien-Hsing Chang, Michele J Losman, et al.
EJNMMI Research
|
January 31, 2012
Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method
Rafke Schoffelen, Winette Ta van der Graaf, Robert M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2006
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide
William J McBride, Pat Zanzonico, Robert M Sharkey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2006
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial
Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2012
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers
Robert M Sharkey, Catharina M van Rij, Habibe Karacay, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 22, 2004
Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates
Gary L Griffiths, Chien-Hsing Chang, William J McBride, et al.
Page
of 10